HopeStage
Back to overview

Depression studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 529-540 of 7,264
Drug study icon
RecruitingNCT06833788

Intravenous or oral iron after cesarean birth and postpartum depression

About this title

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

Read the official source — NCT06833788
Official study title

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression: a Multicentric Randomized Open-labelled Controlled Trial

In Paris
DepressionMedication studyAges 18+
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Behavioral study icon
Not Yet RecruitingNCT07027761

Effectiveness of Online Self-help Intervention and a Face-to-face Intervention Versus Usual Care in depression

Official study title

Maternal Mental Health Intervention (MaMHI) Study: A Combined Non-inferiority and Superiority Randomized Controlled Trial Comparing the Clinical and Cost-effectiveness of an Online Self-help Intervention and a Brief Face-to-face Intervention Versus Usual Care in Mothers at Moderate Risk for Perinatal Depression Identified by a Concentration-of-risk Prediction Approach.

This study isn't recruiting yet.

In Leuven
DepressionBehavioural studyAges 16+
Countries
Belgium
Sponsor
Universitaire Ziekenhuizen KU Leuven
Device study icon
Not Yet RecruitingNCT07629050

Functional Electrical Stimulation for MDD

Official study title

Functional Electrical Stimulation for Major Depressive Disorder: A Pilot Randomized Control Trial

This study isn't recruiting yet.

Location not clearly listed
DepressionDevice studyAges 18–70
Countries
Sponsor
Unity Health Toronto
Drug study icon
Not Yet RecruitingNCT07501728

Intranasal Dexmedetomidine for Postpartum Depression Prevention

Official study title

Intranasal Dexmedetomidine for Prevention of Postpartum Depression in Women Receiving Combined Spinal-Epidural Labor Analgesia: A Randomized Controlled Trial

This study isn't recruiting yet.

In Chengdu
DepressionMedication studyAges 18+
Countries
China
Sponsor
Chengdu Jinjiang Maternity and Child Health Hospital
Other study type icon
Not Yet RecruitingNCT07562516

PB-18 Probiotic for Mild to Moderate Depression

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of Bifidobacterium PB-18 in Adults With Mild to Moderate Depressive Disorder and to Explore Its Gut-Brain Axis Mechanisms

This study isn't recruiting yet.

Location not clearly listed
DepressionPlacebo comparisonAges 18–65
Countries
Sponsor
First Affiliated Hospital of Zhejiang University
Behavioral study icon
Not Yet RecruitingNCT07267702

Postpartum 1-Day CBT Study (Türkiye)

Official study title

Cultural Adaptation of a One-Day Online Cognitive Behavioral Therapy Group Workshop for Postpartum Depression in Türkiye: A Pilot Randomized Controlled Trial

This study isn't recruiting yet.

In Istanbul
DepressionBehavioural studyAges 18–45
Countries
Türkiye
Sponsor
Marmara University
Behavioral study icon
Not Yet RecruitingNCT06672432

Preventing Perinatal Depression with an App-Based CBT Program

Official study title

Preventing Perinatal Depression Using an App-based Cognitive Behavioral Therapy Program

This study isn't recruiting yet.

In Chengdu
DepressionInterventional studyAges 18–45
Countries
China
Sponsor
Jintang County Maternal and Child Health Hospital
Drug study icon
CompletedNCT06340958

CLE-100 (Oral Esketamine) for depression

What is this study about?

This study evaluated the safety and effectiveness of CLE-100 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including La Jolla
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Clexio Biosciences Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.